Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Post-anal gut

ABSTRACT: Immunoglobulin A Targets a Unique Subset of the Microbiota in Inflammatory Bowel Disease

PROVIDER: PRJNA674841 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR30811800_1.fastq.gz	Fastqsanger.gz
	SRR30811800_2.fastq.gz	Fastqsanger.gz
	SRR30811900_1.fastq.gz	Fastqsanger.gz
	SRR30811900_2.fastq.gz	Fastqsanger.gz
	SRR30811801_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 408

Similar Datasets

Immunomolecular and reactivity landscapes of gut IgA subclasses in homeostasis and inflammatory bowel diseases.

Project description:The human gut includes plasma cells (PCs) expressing immunoglobulin A1 (IgA1) or IgA2, two structurally distinct IgA subclasses with elusive regulation, function and reactivity. We show here that intestinal IgA1+ and IgA2+ PCs co-emerged early in life, comparably accumulated somatic mutations, and were enriched within short-lived CD19+ and long-lived CD19− PC subsets, respectively. IgA2+ PCs were often clonally related to IgA1+ PCs and a subset of them presumably emerged from IgA1+ precursors. Of note, secretory IgA1 (SIgA1) and SIgA2 dually coated a large fraction of mucus-embedded bacteria, including Akkermansia muciniphila. Disruption of homeostasis by inflammatory bowel disease (IBD) increased newly formed and actively proliferating IgA1+ plasmablasts, depleted long-lived IgA2+ PCs, and increased SIgA1+SIgA2+ gut microbiota. Such increase featured enhanced IgA1 reactivity to pathobionts, including Escherichia coli, combined with depletion of beneficial Akkermansia muciniphila. Thus, gut IgA1 and IgA2 emerge from clonally related PCs and show unique changes of both frequency and reactivity in IBD.

2024-10-17 | GSE268929 | GEO

human gut metagenome

Project description:Pediatric Inflammatory Bowel Disease Consortium Cohort

| PRJNA297124 | ENA

human gut metagenome

Project description:Human gut microbiome in inflammatory bowel disease

| PRJNA423297 | ENA

Gut Microbial Ecosystem Multiomics in Inflammatory Bowel Disease

Project description:Using multiple omics approaches to explore the effect of the gut microbial ecosytem on inflammatory bowel disease

2019-07-02 | MSV000084050 | MassIVE

Gut Microbial Ecosystem Multiomics in Inflammatory Bowel Disease

Project description:Using multiple omics approaches to explore the effect of the gut microbial ecosytem on inflammatory bowel disease

2019-04-05 | PXD008675 | Pride

Homo sapiens

Project description:Inflammatory bowel disease

| PRJNA87281 | ENA

Transcriptome profiling of DSS-induced colonic and anal inflammation and injury in mice

Project description:Oral administration of dextran sulfate sodium (DSS) to mice induces ulceration and inflammation in the colons of mice. These changes are somewhat similar to those seen in human inflammatory bowel disease. Here we provide a full transcriptome (RNA-Seq) analysis of different gastrointestinal tissues in the regions affected by the DSS chemical, at different timepoints during the injury-inflammation-recovery cycle. The profiled regions include the distal colon (rectum), where the histological changes are most pronounced, the mid-colon, the anus, which is relatively resistant to damage, and the squamous neo-epithelium of the colon, a skin-like tissue that is found in the colon and is believed to be associated with wound healing. We find that administration of DSS is associated with upregulation of cytokines and inflammatory markers. Moreover, stem cell markers of the homeostatic colonic epithelium are depleted, consistent with reprogramming of epithelia to adopt a wound-healing phenotype. Thus, this dataset faithfully recovers broad changes in gene expression in a mouse model of inflammatory bowel disease-like damage.

2022-02-14 | GSE168053 | GEO

Allocryptopine alleviates IBD through modulating gut microbiota and inhibiting Cx3cl1-Cx3cr1 axis/NF-κB/apoptosis in DSS-induced mice

Project description:To explore the anti-inflammatory bowel disease (IBD) ability of allocryptiine based on label-free quantitative proteomics

2022-12-12 | PXD038736 |

gut metagenome

Project description:Fecal Microbiota Transplantation in a dog with inflammatory bowel disease

| PRJDB10694 | ENA

human gut metagenome

Project description:Discovery of disease-adapted bacterial lineages in inflammatory bowel diseases

| PRJNA993675 | ENA